Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin analogues for volume reduction in polycystic liver disease
2009-017849-57Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of octreotide and lanreotide in Polycystic liver disease (PLD) and autosomal dominant polycystic kidney disease (ADPKD), sponsored by Radboud University Medical Center. Started Jan 2010; status: completed.
02
Drugs
octreotidelanreotide
03
Conditions
Polycystic liver disease (PLD)autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on 2009-017849-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017849-57.